Kura Oncology Insider Files Form 144 to Sell 8,805 PSUs

Rhea-AI Filing Summary

Kura Oncology (KURA) filed a Form 144 reporting a proposed sale of 8,805 shares of common stock valued at $79,685.25. The shares were acquired as performance stock units (PSUs) on 09/27/2025 and the proposed sale date is 09/29/2025 through Morgan Stanley Smith Barney LLC on the NASDAQ. The filing shows 87,015,518 shares outstanding, and declares no securities sold by the reporting person in the prior three months. The filer certifies they are unaware of undisclosed material adverse information.

Insights

Financial Analyst

TL;DR: Small insider sale of PSUs; immaterial to overall capitalization but confirms planned immediate monetization of awarded units.

The Form 144 discloses a proposed sale of 8,805 shares valued at $79,685.25, representing a very small fraction of the 87,015,518 shares outstanding. The shares were acquired as PSUs on 09/27/2025 with a planned sale on 09/29/2025 via Morgan Stanley Smith Barney LLC on NASDAQ. From a capital markets perspective, the size and timing suggest this is routine execution of compensation-related awards rather than a signal of company-wide financial stress. No prior sales in the past three months are reported.

Corporate Governance Expert

TL;DR: Disclosure aligns with Rule 144 requirements; filer attests to absence of undisclosed material information.

The filing provides required disclosure elements: acquisition date (09/27/2025), nature of acquisition (PSU), broker details, intended sale date (09/29/2025), and outstanding share count. The signature attestation reiterates compliance with Rule 144 and absence of undisclosed material adverse information. No aggregated sales in the prior three months are reported. Procedurally, the document appears complete for its purpose and does not raise governance red flags based on the disclosed facts alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	8805	79685.25	87015518	09/29/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/27/2025	PSU	Issuer			8805	09/29/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does KURA's Form 144 report?

The filing reports a proposed sale of 8,805 common shares valued at $79,685.25 to be executed on 09/29/2025.

How were the shares acquired according to the Form 144?

The shares were acquired as performance stock units (PSUs) on 09/27/2025 from the issuer.

Which broker is handling the sale and on which exchange will it trade?

The broker listed is Morgan Stanley Smith Barney LLC and the sale is planned on NASDAQ.

How many total shares outstanding does the filing show for KURA?

The filing reports 87,015,518 shares outstanding.

Did the filer report any securities sold in the past three months?

No. The form states Nothing to Report for securities sold during the past three months.